AUTL logo

Autolus Therapeutics plc (AUTL)

Profile

Full Name

Autolus Therapeutics plc

Ticker

NASDAQ: AUTL

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United Kingdom

IPO

June 22, 2018

Indexes

Not included

Website

https://www.autolus.com

Employees

647

Key Details

Price

$2.33(-0.85%)

Market cap

$620.11M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$10.12M(+496.00% YoY)

Annual EPS

-$0.86(+28.33% YoY)

PE ratio

-

Next earnings date

Aug 12, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $2.33
    AUTL price is $2.33

    30-Day Relative Volume

    0.83
    AUTL 30-day relative volume is 0.83

    Price Performance

    Price Most recent change

    -0.85%
    AUTL price was down -0.85% on Aug 8, 2025

    Price YTD change

    -0.85%
    AUTL price is down -0.85% since January 1st

    Price 1-year change

    -35.99%
    AUTL price is down -35.99% year-on-year

    Price 3-year change

    -29.82%
    AUTL price is down -29.82% over the past 3 years

    Price Range

    Price All-time high

    $53.24
    AUTL price is currently -95.62% below its historical high of $53.24

    Price 3-year low

    $1.10
    AUTL price is currently +110.86% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $620.11M
    AUTL market capitalization is $620.11 million

    Market cap 3-year change

    +109.88%
    AUTL market capitalization is up +109.88% over the past 3 years

    Market cap All-time high

    $1.93B
    AUTL market capitalization is currently -67.83% below its historical high of $1.93 billion

    Market cap sector rank

    68.93%
    AUTL market capitalization is higher than 68.93% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +0.02%
    AUTL shares outstanding is up +0.02% year-on-year

    Shares Outstanding 3-Year Change

    +192.75%
    AUTL shares outstanding is up +192.75% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.19
    AUTL beta is 1.19

    200-day SMA

    $2.25
    AUTL price is currently +3.37% above its 200-day simple moving average

    50-day SMA

    $2.31
    AUTL price is currently +0.87% above its 50-day simple moving average

    RSI

    46.82
    AUTL 14-day relative strength index is 46.82

    Volume

    0.83
    AUTL 30-day relative volume is 0.83

    ATR

    $0.13
    AUTL average true range is $0.13

    10-day Historical Volatility

    35.47%
    AUTL 10-day historical volatility is 35.47%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $10.12M
    AUTL annual revenue is $10.12 million

    Revenue Analysts estimate

    $57.14M
    AUTL annual revenue is currently -82.29% lower than the consensus analysts' forecast

    Revenue 1-year change

    +496%
    AUTL annual revenue is up +496% year-on-year

    Revenue Sector rank

    27.68%
    AUTL annual revenue is higher than 27.68% of companies in Healthcare sector

    EPS

    EPS

    -$0.86
    AUTL annual earnings per share is -$0.86

    EPS Analysts estimate

    -$0.91
    AUTL annual earnings per share is currently -5.00% lower than the consensus analysts' forecast

    EPS 1-year change

    +28.33%
    AUTL annual earnings per share is up +28.33% year-on-year

    EPS Sector rank

    59%
    AUTL annual earnings per share is higher than 59% of companies in Healthcare sector

    Profit

    Gross profit

    -$1.27M
    AUTL annual gross profit is -$1.27 million

    Gross margin

    -12.52%
    AUTL annual gross profit margin is -12.52%

    Operating profit

    -$240.79M
    AUTL annual operating income is -$240.79 million

    Operating margin

    -2379.34%
    AUTL annual operating profit margin is -2379.34%

    Net income

    -$220.66M
    AUTL annual net profit is -$220.66 million

    Net margin

    -2180.45%
    AUTL annual net profit margin is -2180.45%

    Expenses

    Total expenses

    $250.91M
    AUTL annual total expenses is $250.91 million

    Operating expenses

    $239.52M
    AUTL annual total operating expenses is $239.52 million

    Cost of goods sold

    $11.39M
    AUTL annual cost of goods sold is $11.39 million

    Selling, general & administrative expenses

    $101.09M
    AUTL annual SGA is $101.09 million

    Depreciation and amortization

    $7.72M
    AUTL annual depreciation & amortization is $7.72 million

    Interest expense

    $9.29M
    AUTL annual interest expense is $9.29 million

    Income tax

    $1.53M
    AUTL annual income tax is $1.53 million

    EBIT & EBITDA

    EBIT

    -$209.84M
    AUTL annual earnings before interest & taxes is -$209.84 million

    EBITDA

    -$202.12M
    AUTL annual EBITDA is -$202.12 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $782.73M
    AUTL annual total assets is $782.73 million

    Non current assets

    $121.80M
    AUTL annual long term assets is $121.80 million

    Current assets

    $660.93M
    AUTL annual total current assets is $660.93 million

    Cash and cash equivalents

    $227.38M
    AUTL annual cash & cash equivalents is $227.38 million

    Accounts receivable

    $15.00K
    AUTL annual accounts receivable is $15.00 thousand

    Inventory

    $4.14M
    AUTL annual inventory is $4.14 million

    Liabilities

    Total liabilities

    $355.40M
    AUTL annual total liabilities is $355.40 million

    Long term liabilities

    $294.66M
    AUTL annual total long term liabilities is $294.66 million

    Current liabilities

    $60.74M
    AUTL annual total current liabilities is $60.74 million

    Accounts payable

    $1.97M
    AUTL annual accounts payable is $1.97 million

    Debt

    Total debt

    $52.63M
    AUTL annual total debt is $52.63 million

    Total debt 1-year change

    -0.64%
    AUTL annual total debt is down -0.64% year-on-year

    Long term debt

    $49.63M
    AUTL annual long term debt is $49.63 million

    Short term debt

    $3.00M
    AUTL annual short term debt is $3.00 million

    Equity & Capital

    Shareholders equity

    $427.32M
    AUTL annual stockholders equity is $427.32 million

    Book value

    $427.32M
    AUTL annual book value is $427.32 million

    Retained earnings

    -$1.10B
    AUTL annual retained earnings is -$1.10 billion

    Working capital

    $600.19M
    AUTL annual working capital is $600.19 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$206.27M
    AUTL annual cash flow from operations is -$206.27 million

    Cash from operations 1-year change

    -41.68%
    AUTL annual cash flow from operations is down -41.68% year-on-year

    Cash from investing

    -$394.55M
    AUTL annual cash flow from investing activities is -$394.55 million

    Cash from investing 1-year change

    -3491.41%
    AUTL annual cash flow from investing activities is down -3491.41% year-on-year

    Cash from financing

    $589.55M
    AUTL annual cash flow from financing activities is $589.55 million

    Cash from financing 1-year change

    +66867.16%
    AUTL annual cash flow from financing activities is up +66867.16% year-on-year

    CAPEX

    CAPEX

    $34.82M
    AUTL annual capital expenditures is $34.82 million

    CAPEX 1-year change

    +216.94%
    AUTL annual capital expenditures is up +216.94% year-on-year

    Free Cash Flow

    Free cash flow

    -$241.09M
    AUTL annual free cash flow is -$241.09 million

    Free cash flow 1-year change

    -53.98%
    AUTL annual free cash flow is down -53.98% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -12.52%
    AUTL annual gross profit margin is -12.52%

    Operating margin

    -2379.34%
    AUTL annual operating profit margin is -2379.34%

    Net margin

    -2180.45%
    AUTL annual net profit margin is -2180.45%

    ROA & ROE

    ROA

    -38.11%
    AUTL annual return on assets is -38.11%

    ROE

    -81.91%
    AUTL annual return on equity is -81.91%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    AUTL price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    AUTL price to earnings ratio is unknown

    PB Ratio

    PB ratio

    1.67
    AUTL price to book ratio is 1.67

    PB ratio Sector rank

    50.37%
    AUTL price to book ratio is higher than 50.37% of companies in Healthcare sector

    PS Ratio

    PS ratio

    68.82
    AUTL price to sales ratio is 68.82

    PS ratio Sector rank

    92.61%
    AUTL price to sales ratio is higher than 92.61% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $582.02M
    AUTL enterprise value is $582.02 million

    Enterprise value Sector rank

    67.84%
    AUTL enterprise value is higher than 67.84% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -2.58
    AUTL EV/EBITDA is -2.58

    EV/EBITDA Sector rank

    33.95%
    AUTL EV/EBITDA is higher than 33.95% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    10.88
    AUTL annual current ratio is 10.88

    Quick ratio

    10.81
    AUTL annual quick ratio is 10.81

    Leverage

    Debt to equity

    0.00
    AUTL annual debt to equity ratio is 0.00

    Interest coverage ratio

    -22.58
    AUTL annual interest coverage ratio is -22.58

    Risk & Stability

    Piotroski F-Score

    -
    AUTL piotroski f-score value is unknown

    Altman Z-Score

    -0.87
    AUTL altman z-score is -0.87

    Analyst ratings

    Recent major analysts updates

    Jul 21, 25 Needham
    Buy
    Jun 12, 25 Needham
    Buy
    Apr 10, 25 Needham
    Buy
    Apr 1, 25 Truist Securities
    Buy
    Mar 21, 25 Wells Fargo
    Overweight
    Jan 13, 25 Needham
    Buy
    Dec 9, 24 Needham
    Buy
    Dec 5, 24 Needham
    Buy
    Nov 18, 24 Goldman Sachs
    Buy
    Nov 15, 24 Redburn Atlantic
    Buy

    Institutional Ownership

    Screeners with AUTL included

    Growing Shares Outstanding
    Stocks with high beta
    UK stocks
    Most recommended stocks
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    • What is the ticker symbol for Autolus Therapeutics plc?
    • Does Autolus Therapeutics plc pay dividends?
    • What sector is Autolus Therapeutics plc in?
    • What industry is Autolus Therapeutics plc in?
    • What country is Autolus Therapeutics plc based in?
    • When did Autolus Therapeutics plc go public?
    • Is Autolus Therapeutics plc in the S&P 500?
    • Is Autolus Therapeutics plc in the NASDAQ 100?
    • Is Autolus Therapeutics plc in the Dow Jones?
    • When was Autolus Therapeutics plc's last earnings report?
    • When does Autolus Therapeutics plc report earnings?

    What is the ticker symbol for Autolus Therapeutics plc?

    The ticker symbol for Autolus Therapeutics plc is NASDAQ:AUTL

    Does Autolus Therapeutics plc pay dividends?

    No, Autolus Therapeutics plc does not pay dividends

    What sector is Autolus Therapeutics plc in?

    Autolus Therapeutics plc is in the Healthcare sector

    What industry is Autolus Therapeutics plc in?

    Autolus Therapeutics plc is in the Biotechnology industry

    What country is Autolus Therapeutics plc based in?

    Autolus Therapeutics plc is headquartered in United Kingdom

    When did Autolus Therapeutics plc go public?

    Autolus Therapeutics plc's initial public offering (IPO) was on June 22, 2018

    Is Autolus Therapeutics plc in the S&P 500?

    No, Autolus Therapeutics plc is not included in the S&P 500 index

    Is Autolus Therapeutics plc in the NASDAQ 100?

    No, Autolus Therapeutics plc is not included in the NASDAQ 100 index

    Is Autolus Therapeutics plc in the Dow Jones?

    No, Autolus Therapeutics plc is not included in the Dow Jones index

    When was Autolus Therapeutics plc's last earnings report?

    Autolus Therapeutics plc's most recent earnings report was on May 15, 2025

    When does Autolus Therapeutics plc report earnings?

    The next expected earnings date for Autolus Therapeutics plc is August 12, 2025
    On this page